Stock listing

NASDAQ:JNCE Jounce Therapeutics Inc Stock

Follow Jounce Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:JNCE

$1.88 USD

Close on May 5, 2023 · No longer trades

Jan 26, 2017 to last close -88.3% · weekly closes, Jan 26, 2017 – May 5, 2023
Lowest – highest close
$0.64 – $28.46 USDSince Jan 26, 2017 · lowest Dec 12, 2022 · highest May 1, 2017

Delisted NASDAQ:JNCE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:JNCE
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Jounce Therapeutics Inc on 6ix

Calls
7 calls with a replay · 7 with a transcript · latest Nov 10, 2022
Decks
13 decks · latest Aug 30, 2022

Events

CallWhenStatus
Jounce Therapeutics (JNCE) Q3 2022 Earnings CallThu, Nov 10, 2022 · 8:00 AM ETReplay
Jounce Therapeutics (JNCE) Q2 2022 Earnings CallThu, Aug 04, 2022 · 8:00 AM ETReplay
Jounce Therapeutics (JNCE) Q1 2022 Earnings CallThu, May 05, 2022 · 8:00 AM ETReplay
Jounce Therapeutics (JNCE) Q4 2021 Earnings CallWed, Mar 02, 2022 · 8:00 AM ETReplay
Jounce Therapeutics (JNCE) Q3 2021 Earnings CallThu, Nov 04, 2021 · 8:00 AM ETReplay
Jounce Therapeutics (JNCE) Q2 2021 Earnings CallThu, Aug 05, 2021 · 8:00 AM ETReplay
Jounce Therapeutics (JNCE) Q1 2021 Earnings CallTue, May 04, 2021 · 8:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2022)Investor deck34 slidesAug 30, 2022
Investor Presentation (March 2022)Investor deck33 slidesMar 7, 2022
Investor Presentation (January 2022)Investor deck31 slidesJan 10, 2022
Investor Presentation (January 2021)Investor deck26 slidesJan 11, 2021
Investor Presentation (April 2020)Investor deck28 slidesApr 7, 2020
Investor Presentation (January 2020)Investor deck26 slidesJan 13, 2020
Investor Presentation (September 2019)Investor deck22 slidesSep 4, 2019
Investor Presentation (January 2019)Investor deck25 slidesJan 7, 2019
Investor Presentation (November 2018)Investor deck29 slidesNov 9, 2018
2018 American Society of Clinical Oncology Annual MeetingConference24 slidesJun 5, 2018
All 13 decks
DeckKindSlidesDate
Technical Presentation (June 2018)Technical18 slidesJun 4, 2018
Investor Presentation (January 2018)Investor deck25 slidesJan 8, 2018
AACR Annual Meeting 2017Conference27 slidesApr 3, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Robert Iannone
Other companies: Pliant Therapeutics, Inc. (Director · Since at least Jul 9, 2026); Autolus Therapeutics plc (Chair of the Research & Development Committee · Since at least Mar 18, 2026); Jazz Pharmaceuticals plc (EVP, Global Head of R&D & CMO · Since at least May 29, 2019); Iteos Therapeutics Inc (Director · Apr 29, 2021 – Jun 11, 2024 · Past); Immunomedics Inc (CHIEF MEDICAL OFFICER · Apr 12, 2018 – Mar 14, 2019 · Past)
Director · Jan 21, 2020 – May 3, 2023 · Past
Kevin Tang
Other companies: Aurinia Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Sep 12, 2024); Heron Therapeutics, Inc. (Director · Dec 22, 2015 – Dec 31, 2019 · Past); La Jolla Pharmaceutical Co (Director · Aug 19, 2015 – Aug 22, 2022 · Past)
Director · May 3, 2023 – May 3, 2023 · Past
Hugh M Cole
Other companies: Astria Therapeutics Inc (Director · Since at least Jul 26, 2019); Ariad Pharmaceuticals Inc (SVP, Chief Business Officer · Apr 29, 2016 – Feb 16, 2017 · Past)
Chief Operating Officer · Dec 20, 2017 – Jan 9, 2023 · Past
John Duncan Higgons
Other companies: Agios Pharmaceuticals, Inc. (Chief Operating Officer · Jul 23, 2013 – Jan 4, 2016 · Past)
Director · Jan 26, 2017 – Jun 24, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about Jounce Therapeutics Inc.